AlphaStocks

HUM vs MOH

As of Sep 20, 2026, Humana (HUM) scores 5.3/10 and Molina Healthcare (MOH) 6.6/10 on AlphaStocks' five-model composite, so MOH scores higher. HUM trades 20% above its model fair value; MOH trades 23% below its model fair value.

HUM

HUMANA INC

5.3

Consider Buy

$385.96

MOH

MOLINA HEALTHCARE, INC.

6.6

Consider Buy

$201.00

HUM vs MOH: Which is the Better Investment?

HUMANA INC (HUM) scores 5.3/10 while MOLINA HEALTHCARE, INC. (MOH) scores 6.6/10 on AlphaStocks' composite model. MOLINA HEALTHCARE, INC. has the higher composite rating of Consider Buy. On a P/E basis, MOLINA HEALTHCARE, INC. trades at 22.5x, making it the more attractively priced of the two. MOLINA HEALTHCARE, INC. trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricHUMMOH
Scores & Fundamentals
Composite Score5.3/106.6/10
RatingConsider BuyConsider Buy
Price$385.96$201.00
P/E Ratio39.322.5
ROE6.6%11.4%
Market Cap$47B$10B
Fair Value$322.02$261.56
Dividend Yield0.9%
Sector Rank#84 of 168#21 of 168
Model Verdicts
PiotroskiAttractiveNeutral
BuffettCautionAttractive
GrahamNeutralCaution
LynchNeutralNeutral
GreenblattNeutralNeutral
View full HUManalysis →View full MOHanalysis →

Related comparisons

Compare any two stocks →

HUM vs MOH: Which Stock Scores Higher?

HUMANA INC (HUM) and MOLINA HEALTHCARE, INC. (MOH) are both in the Health Care sector. MOH currently leads with a composite score of 6.6/10 (Consider Buy) compared to HUM's 5.3/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer